Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)

Abstract:

Intravenous ascorbic acid (IVAA) is a well-known intervention in medicine, which currently is rarely used

in US hospitals. Due to the unusual and extreme clinical demands of hospitalized COVID-19 patients,

IVAA has been implemented in Chinese hospitals, and data published by the “Expert Group on Clinical

Treatment of New Corona Virus Disease in Shanghai” (direct translation) details the use of IVAA as safe

and effective adjunctive care of hospitalized COVID-19 patients. In the IVAA treated group, there was no

mortality, no reported side effects, and shorter hospital stays universally. In addition, the Shanghai

Expert Group recommends IVAA use in extremely critical settings within COVID-19 patients. IVAA, as an

intervention, is relatively inexpensive and simple for both pharmacy and nursing staff use. The primary

author has also used IVAA in the US under a NIH funded human trial and has extensive subject matter

knowledge and expertise.

Subscribe to access this work and thousands more

Report

Subscribe & Access

Overall Rating

0

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

APA

Dada, O., Olufemi, D & John, A (2020). Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings). Afribary. Retrieved from https://afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020

MLA 8th

Dada, Olufemi, et. al. "Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)" Afribary. Afribary, 02 Jul. 2020, https://afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020. Accessed 25 Apr. 2024.

MLA7

Dada, Olufemi, Dada Olufemi and Adeyanju John . "Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)". Afribary, Afribary, 02 Jul. 2020. Web. 25 Apr. 2024. < https://afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020 >.

Chicago

Dada, Olufemi, Dada Olufemi and Adeyanju John . "Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)" Afribary (2020). Accessed April 25, 2024. https://afribary.com/works/ivaa-covid19-hospital-use-anderson-03-24-2020

Intravenous Ascorbic Acid (IVAA) for COVID-19 Supportive Treatment in Hospitalized COVID-19 Patients (Based on use in China and US settings)

0

Document Details

Related Works